Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,270 publicly listed stocks with a combined market cap of $1.89 Trillion. Kezar Life Sciences Inc leads the sector with a market cap of $1.15 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.89 Trillion
Companies Listed
1,270
Largest Company
Kezar Life Sciences …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1201 |
Kezar Life Sciences Inc
NASDAQ:KZR |
$1.15 Million | $1.15 Million | USA | $0.16 | -3.13% | -6.06% | 10.89 Million |
| 1202 |
Biomotion Sciences Ordinary Shares
NASDAQ:SLXN |
$1.14 Million | $1.14 Million | USA | $2.71 | -1.45% | -45.75% | 349.51 Million |
| 1203 |
Universal Ibogaine Inc
V:IBO |
$1.13 Million | CA$1.56 Million | Canada | CA$0.01 | +0.00% | +0.00% | 0.00 |
| 1204 |
Bioventix
LSE:BVXP |
$1.08 Million | GBX8.88 Billion | UK | GBX1700.00 | +2.72% | +0.00% | 217.53K |
| 1205 |
PHAXIAM Therapeutics S.A.
PA:PHXM |
$1.01 Million | €863.96K | France | €0.10 | +0.00% | +0.00% | 0.00 |
| 1206 |
Integragen
PA:ALINT |
$1.00 Million | €857.95K | France | €0.21 | -17.00% | +5.00% | 1.42 Million |
| 1207 |
Biora Therapeutics Inc
NASDAQ:BIOR |
$994.99K | $994.99K | USA | $0.22 | +0.00% | +0.00% | 0.00 |
| 1208 |
4BASEBIO UK SOCIETAS
LSE:4BB |
$989.13K | GBX8.13 Billion | UK | GBX525.00 | +0.00% | -0.94% | 47.40K |
| 1209 |
BIOCURE TECHNOLOGY INC.
F:1WH |
$960.84K | €821.86K | Germany | €0.02 | +16.67% | +31.25% | 0.00 |
| 1210 |
Ondine Biomedical Inc
LSE:OBI |
$916.61K | GBX7.53 Billion | UK | GBX14.50 | -1.69% | +11.54% | 10.73 Million |
| 1211 |
Geneuro SA
PA:GNRO |
$911.56K | €779.71K | France | €0.03 | +0.00% | +0.00% | 0.00 |
| 1212 |
Ovoca Gold PLC
IR:OVXA |
$856.42K | €732.54K | Ireland | €0.01 | +0.00% | +0.00% | 0.00 |
| 1213 |
Biophytis S.A.
PA:ALBPS |
$752.91K | €644.00K | France | €0.02 | +0.00% | -18.62% | 69.39 Million |
| 1214 |
ALGERNON PHARMACEUT. A
F:AGW0 |
$740.91K | €633.74K | Germany | €0.02 | -2.63% | -43.94% | 9.24K |
| 1215 |
Protagenic Therapeutics
NASDAQ:PTIX |
$733.13K | $733.13K | USA | $0.41 | +2.27% | -23.06% | 100.91K |
| 1216 |
Enveric Biosciences Inc
NASDAQ:ENVB |
$710.07K | $710.07K | USA | $1.37 | -7.43% | -21.71% | 5.69 Million |
| 1217 |
Diagonal Bio AB
ST:DIABIO |
$703.53K | Skr6.54 Million | Sweden | Skr0.00 | +0.00% | -20.00% | 262.11 Million |
| 1218 |
Poolbeg Pharma PLC
LSE:POLB |
$676.03K | GBX5.56 Billion | UK | GBX7.88 | +3.68% | -0.25% | 75.65 Million |
| 1219 |
IO Biotech Inc
NASDAQ:IOBT |
$611.57K | $611.57K | USA | $0.01 | +3.66% | +150.00% | 11.67 Million |
| 1220 |
Windtree Therapeutics Inc
NASDAQ:WINT |
$606.76K | $606.76K | USA | $0.02 | -10.00% | +80.00% | 1.54 Million |
| 1221 |
Faron Pharmaceuticals Oy
LSE:FARN |
$582.06K | GBX4.78 Billion | UK | GBX42.00 | -6.67% | -6.67% | 1.97 Million |
| 1222 |
PROMIS NEUROSCIENCES
F:23J0 |
$576.86K | €493.42K | Germany | €6.90 | +2.99% | +1849.15% | 243.66K |
| 1223 |
BRAXIA SCIENTIFIC CORP.
F:4960 |
$566.56K | €484.61K | Germany | €0.00 | +0.00% | +0.00% | 0.00 |
| 1224 |
Waverley Pharma Inc
V:WAVE |
$540.00K | CA$746.49K | Canada | CA$0.02 | +50.00% | +0.00% | 298.38K |
| 1225 |
Hemogenyx Pharmaceuticals PLC
LSE:HEMO |
$486.30K | GBX4.00 Billion | UK | GBX745.50 | -4.36% | -2.42% | 420.83K |
| 1226 |
CERo Therapeutics Holdings, Inc. Common Stock
NASDAQ:CERO |
$478.19K | $478.19K | USA | $0.01 | -7.69% | +0.00% | 18.75 Million |
| 1227 |
Enlivex Therapeutics Ltd
TA:ENLV |
$451.85K | ILA168.54 Million | Israel | ILA0.71 | -12.38% | -99.74% | 4.92 Million |
| 1228 |
CELLECTAR NEW22 DL-00001
F:NV4 |
$451.63K | €386.30K | Germany | €0.25 | -12.67% | +0.00% | 53.50K |
| 1229 |
ORUM
KQ:475830 |
$429.83K | ₩634.26 Million | Korea | ₩63700.00 | +0.79% | +16.03% | 6.48 Million |
| 1230 |
ALBERT LABS INTL. CORP.
F:VB50 |
$372.07K | €318.25K | Germany | €0.01 | +0.00% | +0.00% | 0.00 |
| 1231 |
Lidds AB
ST:LIDDS |
$361.27K | Skr3.36 Million | Sweden | Skr0.02 | +0.00% | +17.14% | 8.44 Million |
| 1232 |
Vaxil Bio Ltd
V:VXL |
$356.72K | CA$493.12K | Canada | CA$0.18 | +0.00% | +0.00% | 11.31K |
| 1233 |
Qlucore AB (publ)
ST:NOVKAN |
$326.04K | Skr3.03 Million | USA | Skr0.03 | -43.95% | -54.46% | 38.54 Million |
| 1234 |
Oxurion NV
BR:OXUR |
$319.29K | €273.10K | Belgium | €0.00 | +33.33% | +25.00% | 43.13 Million |
| 1235 |
SkinBioTherapeutics PLC
LSE:SBTX |
$307.45K | GBX2.53 Billion | UK | GBX9.75 | +0.00% | +24.20% | 55.90 Million |
| 1236 |
Arecor Therapeutics PLC
LSE:AREC |
$287.12K | GBX2.36 Billion | UK | GBX62.50 | +0.00% | -9.42% | 792.03K |
| 1237 |
ImmuPharma PLC
LSE:IMM |
$281.37K | GBX2.31 Billion | UK | GBX4.60 | +4.55% | +2.22% | 45.40 Million |
| 1238 |
PCI Biotech Holding ASA
OL:PCIB |
$274.95K | Nkr2.61 Million | Norway | Nkr0.07 | -39.13% | -53.95% | 22.88 Million |
| 1239 |
Virpax Pharmaceuticals Inc
NASDAQ:VRPX |
$273.35K | $273.35K | USA | $0.22 | +0.00% | +0.00% | 157.00 |
| 1240 |
IXICO PLC
LSE:IXI |
$232.14K | GBX1.91 Billion | UK | GBX8.75 | +0.00% | +1.16% | 3.08 Million |
| 1241 |
Kiromic Biopharma Inc
NASDAQ:KRBP |
$214.93K | $214.93K | USA | $22.05 | +0.48% | +2.11% | 31.00 |
| 1242 |
Lipella Pharmaceuticals Inc. Common Stock
NASDAQ:LIPO |
$194.07K | $194.07K | USA | $0.11 | +31.25% | +31.25% | 798.80K |
| 1243 |
Roquefort Investments PLC
LSE:ROQ |
$184.27K | GBX1.51 Billion | UK | GBX9.25 | +873.68% | +802.44% | 23.80 Million |
| 1244 |
HAVN LIFE SCIENCES INC.
F:5NP0 |
$172.31K | €147.39K | Germany | €0.01 | +0.00% | +0.00% | 0.00 |
| 1245 |
Cizzle Biotechnology Holdings PLC
LSE:CIZ |
$168.80K | GBX1.39 Billion | UK | GBX3.50 | +11.11% | +14.75% | 47.25 Million |
| 1246 |
Fusion Antibodies PLC
LSE:FAB |
$165.94K | GBX1.36 Billion | UK | GBX12.00 | +2.13% | -4.00% | 8.12 Million |
| 1247 |
Aptamer Group PLC
LSE:APTA |
$164.07K | GBX1.35 Billion | UK | GBX0.50 | -4.76% | -4.76% | 68.38 Million |
| 1248 |
QuiaPEG Pharmaceuticals Holding AB
ST:QUIA |
$141.00K | Skr1.31 Million | Sweden | Skr0.00 | -16.67% | -44.44% | 1.38 Billion |
| 1249 |
Scandion Oncology A/S
ST:SCOL |
$103.58K | Skr962.52K | Sweden | Skr0.00 | -39.71% | -19.61% | 342.88 Million |
| 1250 |
Lipigon Pharmaceuticals AB
ST:LPGO |
$97.81K | Skr908.90K | Sweden | Skr0.00 | -44.44% | -61.54% | 559.62 Million |
| 1251 |
NANOSPHERE HEA.SCIENCES
F:2CG |
$90.10K | €77.06K | Germany | €0.01 | +0.00% | +0.00% | 0.00 |
| 1252 |
OptiBiotix Health Plc
LSE:OPTI |
$74.78K | GBX614.64 Million | UK | GBX5.95 | -4.03% | -6.30% | 8.20 Million |
| 1253 |
Vincerx Pharma, Inc. Common Stock
NASDAQ:VINC |
$66.48K | $66.48K | USA | $0.01 | -3.05% | -3.79% | 109.45K |
| 1254 |
Amur Minerals Corporation
LSE:CRTX |
$66.09K | GBX543.22 Million | UK | GBX10.50 | +0.00% | -4.55% | 5.54 Million |
| 1255 |
Nuformix plc
LSE:NFX |
$52.62K | GBX432.50 Million | UK | GBX0.21 | +0.00% | +21.66% | 889.94 Million |
| 1256 |
Futura Medical
LSE:FUM |
$42.44K | GBX348.80 Million | UK | GBX0.60 | +9.09% | +0.00% | 87.79 Million |
| 1257 |
Physiomics Plc
LSE:PYC |
$28.95K | GBX237.93 Million | UK | GBX0.53 | +0.00% | -12.50% | 158.00 Million |
| 1258 |
BSF Enterprise Plc
LSE:BSFA |
$17.57K | GBX144.42 Million | UK | GBX1.13 | +2.27% | -50.00% | 313.56 Million |
| 1259 |
Trevena Inc
NASDAQ:TRVN |
$9.50K | $9.50K | USA | $0.01 | +1000.00% | -0.90% | 3.27K |
| 1260 |
Aditxt Inc.
NASDAQ:ADTX |
$8.89K | $8.89K | USA | $0.01 | -15.50% | -78.16% | 4.24 Billion |
| 1261 |
Carisma Therapeutics Inc.
NASDAQ:CARM |
$8.37K | $8.37K | USA | $0.02 | +261.02% | +12.11% | 1.22 Million |
| 1262 |
CannBioRx Life Sciences Corp
NASDAQ:ATNFW |
$4.11K | $4.11K | USA | $0.43 | -6.52% | +4200.00% | 64.47 Million |
| 1263 |
Effector Therapeutics Inc
NASDAQ:EFTR |
$940.00 | $940.00 | USA | $0.00 | +200.00% | +200.00% | 77.63K |
| 1264 |
Tissue Regenix Group Plc
LSE:TRX |
$628.37 | GBX5.16 Million | UK | GBX0.07 | +0.00% | -99.19% | 22.85 Million |
| 1265 |
Lixte Biotechnology Holdings Inc
NASDAQ:LIXTW |
$218.86 | $218.86 | USA | $0.02 | -0.45% | -68.35% | 1.02 Million |
| 1266 |
NLS Pharmaceutics AG
NASDAQ:NLSPW |
$170.18 | $170.18 | USA | $0.02 | -0.56% | +37.69% | 1.50 Million |
| 1267 |
Neovacs S.A.
PA:ALNEV |
$95.00 | €81.26 | France | €0.00 | +0.00% | +0.00% | 658.06 Million |
| 1268 |
Seelos Therapeutics, Inc.
NASDAQ:SEELQ |
$58.00 | $58.00 | USA | $0.00 | +0.00% | +0.00% | 445.00 |
| 1269 |
Reviva Pharmaceuticals Holdings Inc
NASDAQ:RVPHW |
$29.48 | $29.48 | USA | $0.00 | -16.67% | -69.07% | 3.22 Million |
| 1270 |
immatics biotechnologies GmbH
NASDAQ:IMTXW |
$5.72 | $5.72 | USA | $0.00 | -88.46% | -96.59% | 312.86K |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries